High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.

Rohatiner, A Z; Bassan, R; Raimondi, R; Amess, J A; Arnott, S; Personen, A; Rodeghiero, F; Barbui, T; Bradburn, M J; Carter, M; Lister, T A

Rohatiner, A Z; Bassan, R; Raimondi, R; Amess, J A; Arnott, S; Personen, A; Rodeghiero, F; Barbui, T; Bradburn, M J; Carter, M; Lister, T A.

Affiliation

Rohatiner AZ; ICRF Medical Oncology Unit, Dept of Medical Oncology, St. Bartholomewis Hospital, London, UK. a.rohatiner@icrf.icnet.uk

Ann Oncol ; 11(8): 1007-15, 2000 Aug.

Article in En | MEDLINE | ID: mdl-11038038

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Marrow Transplantation; Leukemia, Myeloid, Acute/therapy; Adolescent; Adult; Age Factors; Cytarabine/administration & dosage; Doxorubicin/administration & dosage; Female; Humans; Male; Middle Aged; Neutropenia/chemically induced; Prognosis; Survival Analysis; Thioguanine/administration & dosage; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Bone Marrow Transplantation Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links